Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Don Owens, Deputy Director of Communications
w. (202) 588-7767

David Rosen, Press Officer, Regulatory Affairs
w. (202) 588-7742

Luis Castilla, Press Officer, Public Citizen’s Texas office
w. (512) 637-9467

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog

Follow us on Twitter


Sept. 1, 2010

Study Reinforces Long-Known Dangers of Weight-Loss Drug Meridia

Statement of Dr. Sidney Wolfe, Director,
Public Citizen’s Health Research Group

It is no surprise that a study published today in the New England Journal of Medicine shows that the weight loss drug Meridia increases the risk of strokes and heart attacks.

In 2002, we petitioned the Food and Drug Administration (FDA) to ban Meridia because: 1) in pre-approval randomized trials, it significantly increased heart rate and blood pressure – both risk factors for heart attacks and strokes, and 2) because the FDA’s 1996 advisory committee voted narrowly against its approval, also opposed by the FDA medical officer reviewing the drug. By 2002, after its 1997 approval, cases of otherwise unexplained heart attacks in young Meridia users had been reported to the FDA.

In its 2005 denial of our petition, the FDA pointed toward the then-ongoing SCOUT trial, which it described as a “landmark” study “examining, for the first time, whether drug-induced weight loss reduces the risk for fatal and nonfatal cardiovascular disease.”

Although SCOUT clearly showed increased risk of heart attack and stroke, and the European Medicines Agency recommended banning the drug in early 2010 based on its overall results, the FDA has unconscionably allowed this drug, which should not have been approved in the first place, to stay on the market.

As is the case with Avandia, Darvon and other drugs, the agency appears immobilized to act against drugs without any unique benefits but unique, serious dangers.


Copyright © 2017 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.